US Stock MarketDetailed Quotes

CYTK Cytokinetics

Watchlist

47.670
-2.190-4.39%

Close Nov 21 16:00 ET

47.800
+0.130+0.27%

Post 20:01 ET

5.63BMarket Cap-8860P/E (TTM)

Cytokinetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-5.50%-101.5M

18.47%-99.31M

-5.91%-129.51M

-38.33%-414.33M

24.60%-74.04M

-14.48%-96.21M

-34.63%-121.81M

-356.10%-122.29M

-110.15%-299.52M

-119.48%-98.19M

Net income from continuing operations

-24.05%-160.55M

-11.41%-143.32M

-3.32%-135.64M

-35.30%-526.24M

0.35%-136.9M

9.06%-129.42M

-549.03%-128.64M

-46.78%-131.29M

-80.65%-388.96M

-349.39%-137.38M

Operating gains losses

---700K

----

-98.75%35K

--0

--1K

-98.74%34K

--2.8M

--0

Depreciation and amortization

30.04%2.41M

29.70%2.41M

26.14%2.33M

104.54%11.89M

282.09%6.34M

31.68%1.85M

31.84%1.86M

37.81%1.85M

155.45%5.81M

125.89%1.66M

Other non cash items

97.87%22.09M

-36.49%6.61M

-28.88%7.89M

-56.95%24.83M

-209.01%-7.84M

-64.94%11.17M

9.43%10.41M

21.66%11.1M

78.10%57.68M

-24.91%7.19M

Change In working capital

567.39%9.88M

140.53%9.77M

-34.05%-25.7M

112.50%3.09M

166.50%44.88M

-87.38%1.48M

74.30%-24.1M

-147.35%-19.17M

-392.15%-24.7M

149.48%16.84M

-Change in receivables

83.88%-244K

3,871.43%834K

152.27%449K

-102.00%-1.14M

-43.36%1.22M

-371.65%-1.51M

-99.49%21K

-101.69%-859K

219.56%56.67M

104.20%2.15M

-Change in prepaid assets

1,208.48%4.48M

244.39%8.16M

-307.50%-6.63M

121.53%1.6M

458.44%8.53M

137.62%342K

14.51%-5.65M

-14.42%-1.63M

-0.45%-7.41M

-60.45%1.53M

-Change in payables and accrued expense

34.10%7.23M

115.00%2.36M

-0.08%-15.87M

-11.37%13.62M

213.77%39.84M

-55.25%5.39M

-468.35%-15.75M

-140.25%-15.86M

-4.64%15.37M

149.16%12.7M

-Change in other current liabilities

42.46%-1.58M

41.52%-1.59M

-342.06%-3.65M

-371.72%-10.99M

-1,106.41%-4.71M

-398.47%-2.74M

-85.22%-2.72M

63.28%-825K

-104.94%-2.33M

-94.28%468K

-Change in other working capital

----

---87M

--0

Cash from discontinued investing activities

Operating cash flow

-5.50%-101.5M

18.47%-99.31M

-5.91%-129.51M

-38.33%-414.33M

24.60%-74.04M

-14.48%-96.21M

-34.63%-121.81M

-356.10%-122.29M

-110.15%-299.52M

-119.48%-98.19M

Investing cash flow

Cash flow from continuing investing activities

-161.68%-45.05M

-893.33%-651.55M

-80.28%32.64M

191.27%239.25M

-378.34%-81.41M

124.98%73.04M

25.83%82.13M

357.47%165.5M

-77.38%-262.13M

-38.21%29.25M

Net PPE purchase and sale

-218.64%-701K

-167.09%-1.92M

--0

87.51%-1.42M

97.60%-77K

96.53%-220K

16.34%-717K

57.32%-402K

76.81%-11.34M

81.95%-3.21M

Net investment purchase and sale

-160.54%-44.35M

-884.15%-649.63M

-80.32%32.64M

195.96%240.67M

-350.61%-81.33M

125.61%73.26M

25.29%82.85M

361.93%165.9M

-153.58%-250.8M

-50.14%32.45M

Cash from discontinued investing activities

Investing cash flow

-161.68%-45.05M

-893.33%-651.55M

-80.28%32.64M

191.27%239.25M

-378.34%-81.41M

124.98%73.04M

25.83%82.13M

357.47%165.5M

-77.38%-262.13M

-38.21%29.25M

Financing cash flow

Cash flow from continuing financing activities

-93.68%3.43M

14,895.63%821.01M

1,546.16%103.79M

-57.12%221.32M

464.83%168.8M

-86.06%54.22M

60.28%5.48M

-107.65%-7.18M

61.31%516.17M

53.21%29.89M

Net issuance payments of debt

-1,233.64%-2.89M

-1,257.55%-2.88M

-350.24%-932K

-100.26%-858K

-111.43%-222K

-100.06%-217K

20.60%-212K

99.57%-207K

--334.66M

---105K

Net common stock issuance

--0

--613.2M

--93.64M

--164.23M

--162.92M

--1.31M

--0

Proceeds from stock option exercised by employees

102.27%6.32M

87.88%10.69M

732.59%29.53M

5.22%18.46M

69.57%6.1M

-49.51%3.12M

54.41%5.69M

-12.96%3.55M

41.70%17.54M

-59.16%3.6M

Net other financing activities

--0

--200M

-75.42%-18.45M

-75.92%39.48M

--0

--50M

--0

-107.64%-10.52M

3,785.37%163.96M

--26.39M

Cash from discontinued financing activities

Financing cash flow

-93.68%3.43M

14,895.63%821.01M

1,546.16%103.79M

-57.12%221.32M

464.83%168.8M

-86.06%54.22M

60.28%5.48M

-107.65%-7.18M

61.31%516.17M

53.21%29.89M

Net cash flow

Beginning cash position

176.06%190.52M

16.60%120.35M

68.79%113.4M

-40.37%67.18M

-5.81%100.07M

-26.29%69.01M

-10.58%103.22M

-40.37%67.18M

35.77%112.67M

17.31%106.24M

Current changes in cash

-560.92%-143.13M

305.10%70.15M

-80.78%6.93M

201.66%46.24M

134.19%13.35M

146.32%31.05M

-56.95%-34.2M

1,207.47%36.03M

-253.24%-45.48M

-276.69%-39.06M

Effect of exchange rate changes

---126K

--16K

--27K

---20K

--0

----

End cash Position

-52.77%47.26M

176.06%190.52M

16.60%120.35M

68.79%113.4M

-5.81%100.07M

-26.29%69.01M

-10.58%103.22M

-40.37%67.18M

Free cash flow

-5.99%-102.2M

17.38%-101.23M

-5.56%-129.51M

-33.75%-415.75M

26.91%-74.11M

-6.70%-96.43M

-34.15%-122.52M

-342.07%-122.69M

-62.41%-310.85M

-62.26%-101.4M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-5.50%-101.5M	18.47%-99.31M	-5.91%-129.51M	-38.33%-414.33M	24.60%-74.04M	-14.48%-96.21M	-34.63%-121.81M	-356.10%-122.29M	-110.15%-299.52M	-119.48%-98.19M
Net income from continuing operations	-24.05%-160.55M	-11.41%-143.32M	-3.32%-135.64M	-35.30%-526.24M	0.35%-136.9M	9.06%-129.42M	-549.03%-128.64M	-46.78%-131.29M	-80.65%-388.96M	-349.39%-137.38M
Operating gains losses	---700K	----	----	-98.75%35K	--0	--0	--1K	-98.74%34K	--2.8M	--0
Depreciation and amortization	30.04%2.41M	29.70%2.41M	26.14%2.33M	104.54%11.89M	282.09%6.34M	31.68%1.85M	31.84%1.86M	37.81%1.85M	155.45%5.81M	125.89%1.66M
Other non cash items	97.87%22.09M	-36.49%6.61M	-28.88%7.89M	-56.95%24.83M	-209.01%-7.84M	-64.94%11.17M	9.43%10.41M	21.66%11.1M	78.10%57.68M	-24.91%7.19M
Change In working capital	567.39%9.88M	140.53%9.77M	-34.05%-25.7M	112.50%3.09M	166.50%44.88M	-87.38%1.48M	74.30%-24.1M	-147.35%-19.17M	-392.15%-24.7M	149.48%16.84M
-Change in receivables	83.88%-244K	3,871.43%834K	152.27%449K	-102.00%-1.14M	-43.36%1.22M	-371.65%-1.51M	-99.49%21K	-101.69%-859K	219.56%56.67M	104.20%2.15M
-Change in prepaid assets	1,208.48%4.48M	244.39%8.16M	-307.50%-6.63M	121.53%1.6M	458.44%8.53M	137.62%342K	14.51%-5.65M	-14.42%-1.63M	-0.45%-7.41M	-60.45%1.53M
-Change in payables and accrued expense	34.10%7.23M	115.00%2.36M	-0.08%-15.87M	-11.37%13.62M	213.77%39.84M	-55.25%5.39M	-468.35%-15.75M	-140.25%-15.86M	-4.64%15.37M	149.16%12.7M
-Change in other current liabilities	42.46%-1.58M	41.52%-1.59M	-342.06%-3.65M	-371.72%-10.99M	-1,106.41%-4.71M	-398.47%-2.74M	-85.22%-2.72M	63.28%-825K	-104.94%-2.33M	-94.28%468K
-Change in other working capital	----	----	----	----	----	----	----	----	---87M	--0
Cash from discontinued investing activities
Operating cash flow	-5.50%-101.5M	18.47%-99.31M	-5.91%-129.51M	-38.33%-414.33M	24.60%-74.04M	-14.48%-96.21M	-34.63%-121.81M	-356.10%-122.29M	-110.15%-299.52M	-119.48%-98.19M
Investing cash flow
Cash flow from continuing investing activities	-161.68%-45.05M	-893.33%-651.55M	-80.28%32.64M	191.27%239.25M	-378.34%-81.41M	124.98%73.04M	25.83%82.13M	357.47%165.5M	-77.38%-262.13M	-38.21%29.25M
Net PPE purchase and sale	-218.64%-701K	-167.09%-1.92M	--0	87.51%-1.42M	97.60%-77K	96.53%-220K	16.34%-717K	57.32%-402K	76.81%-11.34M	81.95%-3.21M
Net investment purchase and sale	-160.54%-44.35M	-884.15%-649.63M	-80.32%32.64M	195.96%240.67M	-350.61%-81.33M	125.61%73.26M	25.29%82.85M	361.93%165.9M	-153.58%-250.8M	-50.14%32.45M
Cash from discontinued investing activities
Investing cash flow	-161.68%-45.05M	-893.33%-651.55M	-80.28%32.64M	191.27%239.25M	-378.34%-81.41M	124.98%73.04M	25.83%82.13M	357.47%165.5M	-77.38%-262.13M	-38.21%29.25M
Financing cash flow
Cash flow from continuing financing activities	-93.68%3.43M	14,895.63%821.01M	1,546.16%103.79M	-57.12%221.32M	464.83%168.8M	-86.06%54.22M	60.28%5.48M	-107.65%-7.18M	61.31%516.17M	53.21%29.89M
Net issuance payments of debt	-1,233.64%-2.89M	-1,257.55%-2.88M	-350.24%-932K	-100.26%-858K	-111.43%-222K	-100.06%-217K	20.60%-212K	99.57%-207K	--334.66M	---105K
Net common stock issuance	--0	--613.2M	--93.64M	--164.23M	--162.92M	--1.31M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	102.27%6.32M	87.88%10.69M	732.59%29.53M	5.22%18.46M	69.57%6.1M	-49.51%3.12M	54.41%5.69M	-12.96%3.55M	41.70%17.54M	-59.16%3.6M
Net other financing activities	--0	--200M	-75.42%-18.45M	-75.92%39.48M	--0	--50M	--0	-107.64%-10.52M	3,785.37%163.96M	--26.39M
Cash from discontinued financing activities
Financing cash flow	-93.68%3.43M	14,895.63%821.01M	1,546.16%103.79M	-57.12%221.32M	464.83%168.8M	-86.06%54.22M	60.28%5.48M	-107.65%-7.18M	61.31%516.17M	53.21%29.89M
Net cash flow
Beginning cash position	176.06%190.52M	16.60%120.35M	68.79%113.4M	-40.37%67.18M	-5.81%100.07M	-26.29%69.01M	-10.58%103.22M	-40.37%67.18M	35.77%112.67M	17.31%106.24M
Current changes in cash	-560.92%-143.13M	305.10%70.15M	-80.78%6.93M	201.66%46.24M	134.19%13.35M	146.32%31.05M	-56.95%-34.2M	1,207.47%36.03M	-253.24%-45.48M	-276.69%-39.06M
Effect of exchange rate changes	---126K	--16K	--27K	---20K	---20K	--0	--0	--0	--0	----
End cash Position	-52.77%47.26M	176.06%190.52M	16.60%120.35M	68.79%113.4M	68.79%113.4M	-5.81%100.07M	-26.29%69.01M	-10.58%103.22M	-40.37%67.18M	-40.37%67.18M
Free cash flow	-5.99%-102.2M	17.38%-101.23M	-5.56%-129.51M	-33.75%-415.75M	26.91%-74.11M	-6.70%-96.43M	-34.15%-122.52M	-342.07%-122.69M	-62.41%-310.85M	-62.26%-101.4M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data